TRPV1 and viral infectious disease: As we move forward, it will be crucial to explore how dietary interventions or TRPV1-targeted therapies could be leveraged to reduce viral burden and improve clinical outcomes in CVB3 and potentially other viral infections associated with EV-mediated transmission.